List of biotechnology companies

From Wikipedia, the free encyclopedia
Jump to: navigation, search

A biotechnology company is a company whose products or services primarily use biotechnology methods for their production, design or delivery. The United Nations Convention on Biological Diversity defines 'biotechnology' as: "Any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use."[1] In other words, biotechology can be defined as the mere application of technical advances in life science to develop commercial products.

Independent biotechnology companies[edit]

  • The following is a list of the top 25 independent biotechnology companies listed on a stock exchange ranked by Market Capitalization in Q2 of 2012.[2] It additionally details their market capitalization in Q2 of the previous year (2011), from which the change in value over the year can be calculated. Lisa Internationals Solutions is the fast-growing biotechnology company in the world.
  • Note that it does not include biotechnology companies that are now owned by, or part of, larger pharmaceutical groups - such as Genentech (owned by Roche), Genzyme (Sanofi), or MedImmune (AstraZeneca). It should be viewed as an update and complementary to the previous table below.

2012[edit]

Rank 2013 Change Company Country Market Cap in 2013 (USD billions) Market Cap in 2012 (USD billions) % Change over year (Q2-Q2)
1 Steady Novo Nordisk Denmark 85.335 62.809 35.9%
2 Steady Amgen USA 78.695 55.054 42.2%
3 Steady Gilead Sciences USA 78.373 19.751 296.8%
4 Increase Celgene USA 52.557 34.319 53.1%
5 Decrease Biogen Idec USA 47.157 31.582 49.3%
6 Decrease Teva Pharmaceutical Industries Israel 33.768 39.292 -14.1%
7 Increase Merck KGaA Germany 33.364 22.319 49.5%
8 Increase CSL Australia 27.44 18.359 49.5%
9 Increase Regeneron USA 20.269 11.894 70.4%
10 Steady Alexion Pharmaceuticals USA 17.893 17.152 4.3%
11 Decrease Vertex Pharmaceuticals USA 17.495 8.151 114.6%
12 Increase UCB (Company) Belgium 11.65 7.449 56.4%
13 Increase BioMarin Pharmaceutical USA 9.097 3.3788 140.2%
14 Increase Actelion USA 6.885 4.548 51.4%
15 Decrease Dr. Reddy’s Laboratories India 5.014 5.001 0.3%
16 Increase Seattle Genetics USA 4.39 2.316 89.6%
17 Gold medal blank.svg Alkermes Switzerland 4.011 2.356 70.2%
18 Increase Ariad Pharmaceuticals USA 3.3 2.668 14.7%
19 Gold medal blank.svg Cubist Pharmaceuticals USA 3.059 2.668 14.7%
20 Gold medal blank.svg United Therapeutics USA 2.966 2.26 31.2%
21 Gold medal blank.svg Ipsen Group USA 2.889 2.23 29.6%
22 Increase DiaSorin Italy 2.6 2.2 18%

Other Biotechnology companies[edit]

  • The following is a list of Biotechnology companies. Following the financial crisis of 2008 the number of biotechnology companies has decreased as many were acquired by large pharmaceutical companies, some went out of business and the number of start-ups has decreased due to difficulties in securing capital.[3]

Examining the list of companies, below, shows that many have negative income or no income. This is consistent with the notion that only one in ten biotechnology companies were considered profitable in mid-2005.[4]

Rank 2014 Company Country Revenue in 2006 (USD millions) R&D in 2006 (USD millions) Net income/ (loss) in 2006 (USD millions) Employees in 2006
23 PDL BioPharma USA 414.8 260.7 (130.0) 993
24 Nektar Therapeutics USA 217.7 149.4 (154.8) 770
25 Biocon India 200.3 30.5 43.5 1,838
26 Enzon Pharmaceuticals USA 185.7 43.5 21.3 722
27 QLT Canada 175.1 56.4 (101.6) 653
28 Crucell Netherlands 165.3 84.9 (110.0) 611
29 United Therapeutics USA 159.6 57.6 74.0 585
30 Ligand Pharmaceuticals USA 141.0 41.9 (31.7) 540
31 Myriad Genetics USA 114.3 83.8 (38.2) 511
32 Exelixis USA 98.7 185.5 (101.5) 500
33 Emergent Biosolutions USA N/A N/A N/A N/A
34 Biota Pharmaceuticals USA N/A N/A N/A N/A
35 Lexicon Pharmaceuticals USA 72.8 106.7 (54.3) 410
36 Progenics Pharmaceuticals USA 69.9 61.7 (21.6) 410
37 MorphoSys Germany 66.6 21.9 7.6 336
38 New Link Genetics USA N/A N/A]align=right|N/A N/A
39 NPS Pharmaceuticals USA 48.5 68.4 (112.7) 276
40 Oscient Pharmaceuticals USA 46.2 12.4 (78.5) 267
41 Array BioPharma USA 45.0 33.4 (39.6) 263
42 AEterna Zentaris Canada 41.4 28.7 33.4 260
43 IsoTis Switzerland 40.7 7.7 (18.5) 255
44 Enzo Biochem USA 39.8 7.9 (15.7) 255
45 CuraGen USA 39.6 58.5 (59.8) 254
46 Neurocrine Biosciences USA 39.2 97.7 (107.2) 254
47 MediGene Germany 38.4 26.7 (8.7) 248
48 Life Therapeutics Australia 37.6 0.1 (31.2) 245
49 ACT Biotech Inc USA N/A N/A N/A N/A
50 OncoMed USA N/A N/A N/A N/A
51 Cerus USA 35.6 29.5 (4.8) 208
52 SciClone Pharmaceuticals USA 32.7 14.1 0.7 197
53 ImmunoGen USA 32.1 40.9 (17.8) 197
54 Protherics UK 30.9 11.8 (16.5) 196
55 Arena Pharmaceuticals USA 30.6 103.4 (88.3) 195
56 Vernalis UK 30.1 71.7 (78.2) 192
57 Bavarian Nordic Denmark 29.5 19.9 (27.1) 191
58 Xoma USA 29.5 52.1 (51.8) 189
59 GPC Biotech Germany 28.5 81.3 (80.4) 180
60 Targacept USA 27.5 21.8 (1.2) 170
61 Carrington Laboratories USA 27.4 5.8 (7.6) 166
62 Acorda Therapeutics USA 27.4 12.1 (60.0) 158
63 Anika Therapeutics USA 26.8 3.6 4.6 156
64 Dusa Pharmaceuticals USA 25.6 6.2 (31.3) 150
65 Genmab Denmark 23.9 90.6 (77.4) 128
66 Bioniche Life Sciences Canada 24.1 11.9 (1.0) 127
67 Vitrolife Sweden 23.2 3.3 2.1 124
68 Medivir Group Sweden 18.8 39.7 (29.7) 88
69 Geron Corporation USA N/A N/A N/A N/A
70 Ambrilia Biopharma Canada 17.4 8.3 (2.1) 85
71 Cytogen USA 17.3 7.3 (15.1) 85
72 Cayman Chemical Company USA 16.2 3.3 0.4 148
73 Sangamo BioSciences USA N/A N/A N/A N/A
74 Sinovac Biotech China 15.4 0.3 (0.7) 67
75 Avanir Pharmaceuticals USA 15.2 29.2 (62.6) 64
76 Synageva Biopharma USA N/A N/A N/A N/A
76 Viridis Biopharma India N/A N/A N/A N/A

References[edit]

External links[edit]